Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nebulized Heparin vs. Placebo for the Treatment of COVID-19 Induced Lung Injury

NCT04397510 is registered in ClinicalTrials.gov with Frederick Health as lead sponsor.

NCT NCT04397510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nebulized Heparin vs. Placebo for the Treatment of COVID-19 Induced Lung Injury
Lead sponsor
Frederick Health
Phase
Phase 4
Overall status
Terminated
Start date
June 1, 2020
Completion date
December 31, 2021
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury, ards, human, covid-19